GLPwatch

Sustained weight loss after treatment with a glucagon-like peptide-1 receptor agonist in an obese patient with schizophrenia and type 2 diabetes.

Am J Psychiatry · 2013

Last updated 2026-07-15
JournalAm J Psychiatry, 2013
Citations23
Relative citation ratio0.82
NIH percentile44
Molecules —
Conditions studied Type 2 Diabetes, Obesity

Full record and abstract on PubMed 23732970 ↗